Pages that link to "Q30239973"

The following pages link to The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA. (Q30239973):

Displaying 47 items.

• MDA5 autoantibody-another indicator of clinical diversity in dermatomyositis (Q33592767) (← links)
• Cancer Screening and Early Detection in the 21st Century (Q38875555) (← links)
• miR-483-5p promotes prostate cancer cell proliferation and invasion by targeting RBM5. (Q47171914) (← links)
• Cancer statistics, 2018. (Q47191906) (← links)
• Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States (Q47433633) (← links)
• Engaging the primary care community to encourage appropriate prostate cancer screening (Q47561590) (← links)
• Metastatic prostate cancer incidence in Australia after amendment to prostate-specific antigen screening guidelines (Q48047521) (← links)
• Understanding temporal trends in medical costs associated with progression to metastatic prostate cancer. (Q48100525) (← links)
• Changes in prostate cancer detection rate of MRI-TRUS fusion vs systematic biopsy over time: evidence of a learning curve. (Q48315464) (← links)
• Impact of a robotic surgical system on treatment choice for men with clinically organ-confined prostate cancer. (Q48321700) (← links)
• Future Perspectives and Challenges of Prostate MR Imaging (Q50112903) (← links)
• PSA screening - for whom and when? (Q50209068) (← links)
• Prostate cancer: Draft USPSTF 2017 recommendation on PSA testing - a sea-change? (Q54153351) (← links)
• Influence of lifestyle and genetic variants in the aldo-keto reductase 1C3 rs12529 polymorphism in high-risk prostate cancer detection variability assessed between US and New Zealand cohorts. (Q55344474) (← links)
• Exnovation of Low Value Care: A Decade of Prostate-Specific Antigen Screening Practices (Q57020549) (← links)
• Landmarks in prostate cancer (Q57105378) (← links)
• Unsuspected Skin Metastasis of Adenocarcinoma of the Prostate in a Patient on Goserelin (Zoladex) (Q57142514) (← links)
• Inverse stage migration patterns in North American patients undergoing local prostate cancer treatment: a contemporary population-based update in light of the 2012 USPSTF recommendations (Q57176678) (← links)
• Factors Related to Prostate-Specific Antigen-Based Prostate Cancer Screening in Primary Care: Retrospective Cohort Study of 120,587 French Men Over the Age of 50 Years (Q57798423) (← links)
• Active surveillance for prostate and thyroid cancers: evolution in clinical paradigms and lessons learned (Q58568619) (← links)
• Essential TNM: a registry tool to reduce gaps in cancer staging information (Q62487294) (← links)
• Prostate care and prostate cancer from the perspectives of undiagnosed men: a systematic review of qualitative research (Q64229459) (← links)
• Interaction between leukocyte aldo-keto reductase 1C3 activity, genotypes, biological, lifestyle and clinical features in a prostate cancer cohort from New Zealand. (Q64890581) (← links)
• Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness (Q89998061) (← links)
• Prostate cancer in young men: An emerging young adult and older adolescent challenge (Q90278196) (← links)
• An integrative DNA methylation model for improved prognostication of postsurgery recurrence and therapy in prostate cancer patients (Q90314695) (← links)
• Systematic Review of Commercially Available Mobile Phone Applications for Prostate Cancer Education (Q90335112) (← links)
• Harnessing cell-free DNA: plasma circulating tumour DNA for liquid biopsy in genitourinary cancers (Q90590637) (← links)
• Prostate cancer: a tale of two sides (Q91691659) (← links)
• Multiparametric MRI for prostate cancer diagnosis: current status and future directions (Q91969165) (← links)
• Prostate Cancer Screening among High-Risk Black Men (Q92002268) (← links)
• Development and Psychometric Properties of a Prostate Cancer Knowledge Scale for African American Men (Q92066633) (← links)
• Validation of an Algorithm for Claims-based Incidence of Prostate Cancer (Q92100760) (← links)
• Prostate cancer in sexual minorities and the influence of HIV status (Q92126108) (← links)
• Prostate-specific antigen glycoprofiling as diagnostic and prognostic biomarker of prostate cancer (Q92181256) (← links)
• Clinical significance of the LacdiNAc-glycosylated prostate-specific antigen assay for prostate cancer detection (Q92402595) (← links)
• Global Consultation on Cancer Staging: promoting consistent understanding and use (Q92461131) (← links)
• Targeted Melanoma Screening: Risk Self-Assessment and Skin Self-Examination Education Delivered During Mammography of Women (Q93200691) (← links)
• Perspective on Prostate Cancer Screening (Q93248739) (← links)
• Serum Levels of Matrix Metalloproteinase-1 in Brazilian Patients with Benign Prostatic Hyperplasia or Prostate Cancer (Q95272652) (← links)
• Fatal prostate cancer incidence trends in the United States and England by race, stage, and treatment (Q95320520) (← links)
• The USPSTF screening recommendation: a swinging pendulum (Q95595115) (← links)
• Detection and Prognosis of Prostate Cancer Using Blood-Based Biomarkers (Q95854974) (← links)
• Determining the impact of Medicaid expansion on cancer burden (Q97078953) (← links)
• Cancer health disparities in racial/ethnic minorities in the United States (Q99234116) (← links)
• Impact of health literacy on shared decision making for prostate-specific antigen screening in the United States (Q101467922) (← links)
• Surgical management of high-risk, localized prostate cancer (Q101564382) (← links)